Protech Home Medical Corp

PTQ-X

Analysis and Opinions about PTQ-X

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
December 30, 2019

They had a cyber theft – 9 Million out of there bank but insurance covered it. He likes it. It is speculative and is a roll up strategy.

Show full opinionHide full opinion

They had a cyber theft – 9 Million out of there bank but insurance covered it. He likes it. It is speculative and is a roll up strategy.

PAST TOP PICK
PAST TOP PICK
December 9, 2019
(A Top Pick Dec 12/18, Up 41%) It continues to grow organically and by acquisition. It is very attractive at less than 8 times earnings, which are growing at 12-15% per year. It will either get recognized by the market or get taken out.
Show full opinionHide full opinion
(A Top Pick Dec 12/18, Up 41%) It continues to grow organically and by acquisition. It is very attractive at less than 8 times earnings, which are growing at 12-15% per year. It will either get recognized by the market or get taken out.
BUY
BUY
August 9, 2019

They've recently announced they had a cyber attack and lost $9 million but they should get most of it back. They'll be then able to go do more mergers and acquisitions after, which should be in September. The valuation is very attractive, and it should bounce up when they make the press release that they have recovered their funds.

Show full opinionHide full opinion

They've recently announced they had a cyber attack and lost $9 million but they should get most of it back. They'll be then able to go do more mergers and acquisitions after, which should be in September. The valuation is very attractive, and it should bounce up when they make the press release that they have recovered their funds.

BUY
BUY
May 1, 2019
In the U.S. healthcare business. They have transformed in the past year, raising profit margins and accounts receivable. They are highly profitable around 20%. Trades at less than 10x 2020's EBITDA. Management continues to execute, doing small acqusitions.
Show full opinionHide full opinion
In the U.S. healthcare business. They have transformed in the past year, raising profit margins and accounts receivable. They are highly profitable around 20%. Trades at less than 10x 2020's EBITDA. Management continues to execute, doing small acqusitions.
TOP PICK
TOP PICK
January 30, 2019
They just released earnings this week and they have been turning their business around -- increasing margins and growing organically. Management owns about 18% of the shares and it trades at 5 times earnings. He thinks it could trade at twice that level. They are involved in patient home monitoring. Yield 0% (Analysts’ price target is $3.00)
Show full opinionHide full opinion
They just released earnings this week and they have been turning their business around -- increasing margins and growing organically. Management owns about 18% of the shares and it trades at 5 times earnings. He thinks it could trade at twice that level. They are involved in patient home monitoring. Yield 0% (Analysts’ price target is $3.00)
Showing 1 to 5 of 5 entries
  • «
  • 1
  • »